Literature DB >> 11597660

Endothelin-receptor antagonists in pulmonary hypertension.

J Dupuis1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11597660     DOI: 10.1016/S0140-6736(01)06298-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

Review 1.  Pulmonary hypertension associated with sickle cell disease: pathophysiology and rationale for treatment.

Authors:  Raymond L Benza
Journal:  Lung       Date:  2008-05-10       Impact factor: 2.584

Review 2.  Pulmonary arterial hypertension in connective tissue disorders: Pathophysiology and treatment.

Authors:  Elisabetta Zanatta; Pamela Polito; Giulia Famoso; Maddalena Larosa; Elena De Zorzi; Elena Scarpieri; Franco Cozzi; Andrea Doria
Journal:  Exp Biol Med (Maywood)       Date:  2019-01-22

3.  Activation of ETB receptors regulates the abundance of ET-1 mRNA in vascular endothelial cells.

Authors:  N Farhat; C C Matouk; A M Mamarbachi; P A Marsden; B G Allen; E Thorin
Journal:  Br J Pharmacol       Date:  2008-02-18       Impact factor: 8.739

4.  Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach.

Authors:  D Mukerjee; D St George; B Coleiro; C Knight; C P Denton; J Davar; C M Black; J G Coghlan
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

Review 5.  Molecular imaging of the pulmonary circulation in health and disease.

Authors:  Jocelyn Dupuis; François Harel; Quang T Nguyen
Journal:  Clin Transl Imaging       Date:  2014-09-09

6.  Clinical perspectives with long-term pulsed inhaled nitric oxide for the treatment of pulmonary arterial hypertension.

Authors:  Robyn J Barst; Richard Channick; Dunbar Ivy; Brahm Goldstein
Journal:  Pulm Circ       Date:  2012 Apr-Jun       Impact factor: 3.017

7.  Pediatric Pulmonary Hypertension: Definitions, Mechanisms, Diagnosis, and Treatment.

Authors:  Devashis Mukherjee; Girija G Konduri
Journal:  Compr Physiol       Date:  2021-06-30       Impact factor: 8.915

Review 8.  A review of pulmonary arterial hypertension: role of ambrisentan.

Authors:  Robyn J Barst
Journal:  Vasc Health Risk Manag       Date:  2007
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.